These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25028165)

  • 1. Hybrid therapy in the management of atrial fibrillation.
    Starek Z; Lehar F; Jez J; Wolf J; Novák M
    Curr Cardiol Rev; 2015; 11(2):167-79. PubMed ID: 25028165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The worldwide social burden of atrial fibrillation: what should be done and where do we go?
    Santini M; Ricci RP
    J Interv Card Electrophysiol; 2006 Dec; 17(3):183-8. PubMed ID: 17372814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the non-surgical management of atrial fibrillation.
    Kamalvand K; Sulke N
    Int J Clin Pract; 1999; 53(1):44-9. PubMed ID: 10344066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Pills and pulses": hybrid therapy for atrial fibrillation.
    Murgatroyd FD
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1 Suppl):S40-6. PubMed ID: 11843466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pharmacological treatments for atrial fibrillation. A critical perspective on the status quo.
    Murgatroyd FD; Leenhardt A
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):7-16. PubMed ID: 10816796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug and electrical therapy of supraventricular tachyarrhythmias].
    Heisel A; Jung J; Schieffer H
    Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
    Huang DT; Monahan KM; Zimetbaum P; Papageorgiou P; Epstein LM; Josephson ME
    J Cardiovasc Electrophysiol; 1998 May; 9(5):462-9. PubMed ID: 9607453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.
    Manolis AG; Katsivas AG; Lazaris EE; Vassilopoulos CV; Louvros NE
    J Interv Card Electrophysiol; 1998 Mar; 2(1):71-6. PubMed ID: 9869999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation in therapy of patients with atrial fibrillation or flutter.
    Waldo AL
    Cardiol Clin; 1990 Aug; 8(3):479-90. PubMed ID: 2205386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention.
    Delfaut P; Saksena S; Prakash A; Krol RB
    J Am Coll Cardiol; 1998 Dec; 32(7):1900-8. PubMed ID: 9857870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.